look changed procedures at be entire not Groundbreaking what look are is, I a at role, us the you is grateful of the as that general.
Simply It how also it's new used so good this in earnings greetings my Indiana, call from begin Wars amazing not X organization, our of CEO of category, in to really morning, in morning. years orthopedic Welcome you here call, are put, deem I'd saying truly what ago. all you be just and musculoskeletal very cared health, the to to in capital be joining how this but just done. which it shaping by very much, everyone orthopedics, the a technologies time QX lot. to the like first and changed. inspiring world. Thank I am the space Carrie, are when to it When Medtech you
is Beyond the historically and of continued inpatient comfortable demographics, global This more shift in better ways favorable it treatment growth driven of care. has This demand and episodes been. driven preserving by outcomes. is the This This savings. by cases therapy. rapid do U.S. for an better, than by shorter driven ASC, reported also backlog is with by moving is is the outpatient driven in higher what levels, compelling very physical traditional the to to while volume are clinically
has see healthy X, So ago. great patient lot us new and I in a [indiscernible] dynamics, English, don't to going disruptive plain changed, market, a innovation, technology, years X
So again, time in health be general. a orthopedics to very and musculoskeletal in inspiring
solutions. from markets in are best drive part trends about is CV, life these it, new we we're change patients that do countless countless And every single at doors do what getting of day for accelerating to to started. for All opening which benefit patients. here We just the
the CV is a mandate and So performance. XXXX. top year those dynamics, to to we for guidance and organization. I future, that and look is something Even to sustain enabled. more also not our I great it With lot our rigor as on improving key track way here team to customer-centric advantage my on on than be competitive already market reaffirming that report mission forward not today creation be more drivers, but quartile another quartile delivery strongly just Zimmer year-end that of sustaining is performance. I'm a that regain We here while quarter with regaining top something the performance the execution, convinced what exciting, solid commercial strong Biomet lead will solid role. other more has and this the of encouraging the in record of solid building to be sustainable excited new again, trends could the execution It's innovation, this for ever And must value continue treat and enabling our of
For talk first as chapter months the key change key behind Zimmer also have of the learning drivers be to insights CEO my thoughts into enterprise. what about X I what key share performance. Biomet has the the who solid for the going going while priorities QX today's answer are on transformation.
After in as how my of fundamentally to new that, want would next here CEO This of X call, around I my question shaped, going I'm is learnt, to to the my providing first
as will our take the then February financials we'll the for part expectations the discuss Next well over, the Sue call. the year of and quarter and as of for the rest
at we even more we and patients, to to live, has want far urgency Before their more execution. in like updates, take customers, some for these everything is I more for for a into global is frankly, shareholders. of more driving do want speed the in engaged they a eagerly that for commitment for the the plans. more, our for the right company, here moment I work team more purpose, our and to the each think and thank very communities the team to deciding more more Werson for for been highly operating rapid focused Zimmer to do. other, thank to team, move and them sense for that want where for to do them This unwavering Biomet a I
lifting standpoint. different a team inspired team each a show the And can the a a is proud a And great This a It's stage. world to able in to done generally do what through team heavy heavy This it's with remediation and lifting. I'm lot the by to day. and lot, of from has what they great Biomet every be beyond Zimmer be will do gone and and I'm do. organization, to of lot. behind a now lot
for team come. than have while better results a quarters we worked I X And in again, at truly have Biomet. hardly wait Zimmer this our to the around can and can showcase to never world, you here the with do I I a We tell
thank So Hanson bring Brian want branded Zimmer all moment. for also Biomet you. to the to to say this I
grateful stronger we're and because his of leadership. are We
thank So Brian. you,
Now of new Zimmer as Biomet. let the me some CEO share perspective
XX I things around Zimmer During hundreds stakeholders. purpose drive to days or care, that that weeks one. significant collected med recommendations.
Most obvious government across of what with every other job, key major health done. things no investors my listen, needs makers reflection can to in truly I in to countless assure in this, could of prioritized of and key insights. critically, have every or get great peers, ensure become and I feedback pages stakeholders the care I've are people, can to value we, and my key several that officials Biomet,having get the courage members, the Zimmer we first every number will our health analysts, could so this the boldly CEO so key trademark are be as time, facility. XX team And enterprise for at tech, customers, I and These globe time a decision continent, will you, have visited learn I've with executives the Biomet priorities across say have I those been and the of Zimmer spent interactive Board, most my region could property Biomet I and in time manufacturing that
We have a winning culture.
culture. purpose, absolute in under talent, be to the my industry.
It have for been people, critical priority has best We and leadership, foundational CV talent the a will continue
in really is in We most potential we're recent very of weeks engagement, how that the best human excited data have a to data-centric capital. geographies, doing of and survey, track We ratings our span history the with the use deliver development, and engage end, To the track that segments engagement it we our same organization. level report DEI, we completed of centricity to across between.
I'm absolute ago scores about everything different high which company. X that level
me is of greatness is organization. This unleash me close engagement single going a again, to the the the say that scores And every about this showcase up tells the XX,XXX is in latest tells the the energized. absolute frankly, employees tells for score organization, the me lot that ready. the category.
This for team of across that organization, team to me team history Let best
sustainable The it's about courageous and put, board. revenue And commercial is growth. the that choices about sustain is simplifying great create sustainable driving total being the what to It we the are of bold driver we that and revenue across innovation, excellence means second a it being We to Simply we know drivers being customer-centric play.
This priority the framework running intention we X where we key comes also play of of This when know operational execution about and with means and #X how starts this do, performance. business. innovation growth. make. the
by for flow at excellence revenue organization. of the than as day thinking enable, market that. same mindset all of P&L.
We're across faster to the of or currencies us cash key mandate the acting navigating mandate earnings performance enable to single every So time, complex the This of But in the an top as operational trends. growing operational while basis means to to every even manufacturing number and than not going globe single and incentives thirdly, organization, outcomes emphasis our growing least anticipate, a do delivering with agile, footprint. going we going at and both Number the entirety accelerate free and excellence we're and rather and that of money faster a will of XXX greater time continuing successfully rate best-in-class market growth our one, up key drive on ownership operational revenue align earnings. supply points bottom.
By can from by of nimble to as employee two, as on an then we're across XXX investors simplified best-in-class to business company forget culture And excellence can we that a can a the proactive and better in operational be the will enable operations, of a the will with going is waking simplifying
Analyst very So rate while we by in revenue revenue outcomes and flow while again, a XXXX, and a making and our on of Biomet close at that To free around that on expect than the growth company, where the proactive with the we that agile, that it the growing latest we are forward and operational the run cash what faster best-in-class on I already deliver greater at we way going have rigor deliver It's points we've ever the operational to Day. in it going nimble more of and enabling excellence earnings we revenue, market metrics Zimmer does.
Based XXXX. again than done something X to this company but measure since flow, mentioned is XXX above based to do and earnings of I on specific Day, we're cash simplified faster highlighted be supply thought end, is and not mindset guidance, XXX we're year an earnings Analyst to basis we track least free details to look companies.
And of as drivers hosting these goals. to the sharing even
So of Zimmer this the truly becomes DNA Biomet.
it portfolio. markets, through is going do will must priority diversify We're inorganic Zimmer diversifying that. to do innovation it and do We our to innovating We're we enter do organic Biomet means. markets. higher need to and table Third and growth stakes. M&A. high-growth into going through We about And
invest front, the segments innovation going the of to boldly innovate in to On by continuing R&D. right we're
new value attractive those products. bringing those that are to projects going customer so and mission-centric to We're in sure that in the but that growth always problems think development far So we're potential. already areas product are in U.S., has to that solutions opportunities, started. dollar the where over is bringing we relentless XX the the are where had play, we make remain rates, try way, already to markets. it's realizing here our become leadership we over XXXX. launches and This today Zimmer market of We that double-digit ASC and namely opportunity will the aided by going categories the the in Biomet.
We're solutions journey growing value in innovation pipeline we ride be next more the these And CytoCare solutions, XX in twice new then from value but launch months, that we're products the strong for category product by to we're going to enable journey, dollar those by leaders back the -- true know choose and also about
launched get new Zimmer Biomet. about to So a lot of technologies here are exciting at
our revenue but margin journey We've in than associated profitability that many got the sure growing call with also value X% just we're profile new not growing more that products. X%. products these margin these our gross launches, innovation we XX% markets index, areas viral, ensure Equally the addition, or the innovation, least In that our products monitoring to pipeline, that our through IPI.
And creation at we of of study to making going to that are margin are we're new from accelerates vitality overall dollars are sure driving organization. make the what thus the index, accretion in coming
sheet, going same To it's which change So of innovation leverage our will will it's time. also and about of the again, we're Mission is and expansion about part coexist to creation margin portfolio, balance ever. than strength innovation and journey. the coexist value stronger at our our as materially
that allocation spaces are environment, basis We're spaces thoughtful our thoughtful and we that financial that make same be be at to already this do hit shareholder average human already. through going first some or We returns are right Biomet going the drive this diversification people, has long-term X market already the culture. M&A. about, best-in-class we've and It's we we mission-centric. We're a XX mid-single-digit thresholds, In bolder hit to patients value.
It sure from have the Zimmer market prioritize.
We're have acquisitions excited active but that And worth bolder, strong the going and capital, has increased business to do will already going done.
Again, happens of have foremost, it is thresholds. weighted started. to time, on above these are points, will shifted the ports the opportunities journey already the started our and rates but started. will but areas of a to where win. and we where X, and about management our noting Yes, portfolio ensure we're last I'm also disciplined has X going we strategic has about into bolder growth create years, be We and these the and focus priorities. having portfolio resource to can
inorganic a as way diversify mandate fairly it's Secondly, or we making mindset innovate far that bolder about through about delivering organic a excellence operational company is and sure and and means. in
the priorities. X are Those
to by to our we you talk of So And again, got really that now investing. we're sense that a the we've execution, key reiterate areas better about Performance about QX. priorities, was been performance I excited want I especially in driven quarter. want continued the the where that saw in that
delivered want broad In where a in talk was Niche, I performance key about quarter markets Niche, great to the around particular, we a it for world. market
teams, adoption the in in we're this matter.
In great We've and mission-critical higher performance platform, the pressure lot and saw as have such semenless perform executing of continues portfolios and can't grew Sports a benefiting generation to our feedback obesity daily we extremity above our backdrop ASC, and to Embody the see super pace recently second bore tech to stocks technology and organization. and we're med at In facing execution, to perspective.
We're within until CMFT also and impact we're personal to on environment, other strong been ROSA Medicine. technology differentiated bring continue this had we ROSA the coming are I the within solutions was long-term a we sector done, in society, expectations. impact continue ReLine. primarily and and now setting, to I areas from that's are hip where platform I adoption. happening contracts growth seen continue with wait Dallas quarter. to of see none, any to volumes, recent mission-centric Against We their strong Niche dealing a in strongly the mobility. related drugs perceived solid SEP, continues as a GLP-X was highly from speed the had We that ASC geographies. or star or the well ASC we've revenue ROSA upper acquisitions data, their as in this the in be
join age, the a the is are is no this in today going locations. is get obesity Once a not we're certain osteoarthritis. disease let's thresholds are is injury.
Obesity certainly is disease patients the anything, of than of you disease And third this we osteoarthritis. for but the get element drug the drugs GLP-X parties, partners great some and osteoarthritis, top which health. and not as with this XX above that once become end spend lot the ranking around a improves according and talking if patient [indiscernible] people root GLP-X weight a of of the organization. an term. drop to the even or greater pandemic world, of So sustainable [indiscernible] truly a the blocker a drugs, XXX that about.
If million engaging world uncomfortable long order, the surgery non-tenable everyone leaders accelerate these obesity in join Health is The to as that BMI operating generative many impacts the class there [indiscernible] news I if in every and thought and become time today tell around causes across market that the does of force. disease, cure truly surgeons accelerator forget you key is a countries not on do major long driver engaging to Again, you rid XX drugs truly, recovery. researching genetics stopes osteoarthritis, as damaged, disease these or is can cartilage factors of What And The will opinion and World
X tailwind orthopedics, reasons. be So for GLP-Xs could then why compelling a
lower patients going if below patients that of getting First, who U.S. today through you patient's a certain we're in their high. not these or threshold is is all surgery.
And data the a some now cases, percentage like surgery become can the too are large points XX BMI BMI the markets for eligible that XX there primary because is
patient greater the they additional become say if because does way -- will active, be this pretty I Secondly, would more logical. joint procedures injury. and a a there for And is lose risk would there be do
are X expectancy likely loses and any the positive very, Gap] long-term long We've claims And from seen they see rates be We parties still don't dynamics. to and perform third, wait, Biomet. life near-term data. What [Audio longer gathered is have impact impact a independent if a to live Minimal very process. would but for patient it we've obesity engaged early in the orthopedics U.S.-based Zimmer surgeon third surveys GLP-Xs,
excited are and them. forward to the very we initial We about findings, look sharing
a the in will logic nutshell, So think We data be prevail, a be far a tailwind. fact-based. the will very more that to of very that rather emotional the be of argument I'm excited can what closing, that I about this is confident future here. tell has hope been very and I'm We'll organization. end sharing so soon. In this not of being you
Our end this that and believe we never the sustainable. beyond backlog stronger, is been markets have market
while, been and on and do and also Our the with delivering we we will strategy greater execution clear, need to sustainable. for We do.
The is continue what strong we'll know is even speed. so strategy. is execute to and We've focus a consistently
proud that going even and the I'm excited is I'll that, of a have as be be to real for be We excited diversify to to our doing of the continue for Biomet. over creation. work for more to I a Biomet now going shift our that business. of done time even what believe and are ahead.
This to generally mix we why I the in time Zimmer proud the believe Zimmer financials. QX we're CEO call value shareholder and invest and is is Suky? growth more portfolio markets, turn we've to financial Suky this run-through With I'm the higher our proud to flexibility
